Academic oncology clinicians’ understanding of biosimilars and information needed before prescribing

BACKGROUND: With increasing numbers of oncology biosimilars in the approval pipeline, it is important to investigate oncology clinicians’ understanding of biosimilars and what information they need prior to adoption. METHODS: Between January and May 2018, 77 oncology clinicians (52 physicians, 16 ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, John W., McGrath, Megan K., Dixon, Margie D., Switchenko, Jeffrey M., Harvey, R. Donald, Pentz, Rebecca D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327341/
https://www.ncbi.nlm.nih.gov/pubmed/30671144
http://dx.doi.org/10.1177/1758835918818335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327341/
https://www.ncbi.nlm.nih.gov/pubmed/30671144
http://dx.doi.org/10.1177/1758835918818335

Ejemplares similares